R1 RCM Inc. (NASDAQ:RCM) Receives $15.79 Average Price Target from Analysts

R1 RCM Inc. (NASDAQ:RCM) has been assigned an average rating of “Hold” from the eighteen analysts that are covering the stock, Marketbeat.com reports. Thirteen equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $15.79.

A number of research analysts have weighed in on the stock. Leerink Partnrs lowered shares of R1 RCM from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Jefferies Financial Group downgraded R1 RCM from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Stephens cut R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 1st. Royal Bank of Canada reiterated an “outperform” rating and set a $19.00 price target on shares of R1 RCM in a report on Friday, June 28th. Finally, Morgan Stanley lowered shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 8th.

Institutional Trading of R1 RCM

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Capital International Investors grew its holdings in shares of R1 RCM by 0.8% in the fourth quarter. Capital International Investors now owns 8,343,199 shares of the healthcare provider’s stock valued at $88,188,000 after purchasing an additional 67,485 shares in the last quarter. Voss Capital LLC increased its position in shares of R1 RCM by 553.9% during the fourth quarter. Voss Capital LLC now owns 7,125,000 shares of the healthcare provider’s stock worth $75,311,000 after acquiring an additional 6,035,340 shares during the period. Norges Bank acquired a new stake in shares of R1 RCM in the fourth quarter valued at $42,539,000. P2 Capital Partners LLC boosted its holdings in R1 RCM by 70,366.3% in the fourth quarter. P2 Capital Partners LLC now owns 3,535,294 shares of the healthcare provider’s stock valued at $37,368,000 after purchasing an additional 3,530,277 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in R1 RCM by 4.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,154,888 shares of the healthcare provider’s stock worth $39,624,000 after purchasing an additional 136,808 shares in the last quarter. 61.10% of the stock is currently owned by hedge funds and other institutional investors.

R1 RCM Stock Up 0.4 %

Shares of RCM opened at $14.04 on Tuesday. The stock has a 50 day moving average price of $12.92 and a 200 day moving average price of $12.62. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.79 and a current ratio of 1.79. The stock has a market capitalization of $5.91 billion, a price-to-earnings ratio of -175.50 and a beta of 0.85. R1 RCM has a one year low of $8.87 and a one year high of $18.22.

R1 RCM (NASDAQ:RCM) last released its earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. The business had revenue of $627.90 million during the quarter, compared to analyst estimates of $633.10 million. R1 RCM had a negative net margin of 1.39% and a negative return on equity of 1.16%. The business’s revenue was up 12.0% compared to the same quarter last year. Equities research analysts forecast that R1 RCM will post -0.2 earnings per share for the current fiscal year.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.